Short Interest in WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Declines By 59.3%

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling 9,096 shares, a decline of 59.3% from the January 15th total of 22,350 shares. Based on an average trading volume of 54,542 shares, the days-to-cover ratio is presently 0.2 days. Based on an average trading volume of 54,542 shares, the days-to-cover ratio is presently 0.2 days.

WuXi Biologics (Cayman) Stock Up 2.9%

OTCMKTS:WXXWY opened at $10.53 on Thursday. WuXi Biologics has a 52-week low of $4.14 and a 52-week high of $11.21. The stock has a fifty day simple moving average of $9.11 and a 200-day simple moving average of $9.01.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.